{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:43:00Z","timestamp":1782603780342,"version":"3.54.5"},"reference-count":69,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.hoc.2007.08.005","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T15:08:55Z","timestamp":1196953735000},"page":"1093-1113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma"],"prefix":"10.1016","volume":"21","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2007.08.005_bib1","first-page":"398","article-title":"Abnormal proteins in myeloma","volume":"5","author":"Waldenstr\u00f6m","year":"1952","journal-title":"Adv Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.hoc.2007.08.005_bib3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.hoc.2007.08.005_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) in 6,995 sera from an adult population","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle","year":"1972","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.hoc.2007.08.005_bib8","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.hoc.2007.08.005_bib9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.hoc.2007.08.005_bib10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2007.08.005_bib13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","article-title":"Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance","volume":"112","author":"Gregersen","year":"2001","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M","article-title":"Cancer risk in patients with monoclonal gammopathy of undetermined significance","volume":"63","author":"Gregersen","year":"2000","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2141.2002.03589.x","article-title":"Monoclonal gammopathy in Iceland: a population-based registry and follow-up","volume":"118","author":"Ogmundsdottir","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.hoc.2007.08.005_bib17","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.hoc.2007.08.005_bib18","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib19","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1182\/blood-2005-02-0761","article-title":"A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS","volume":"106","author":"Chng","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2007.08.005_bib20","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet-Loiseau","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/blood-2004-03-0833","article-title":"Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors","volume":"105","author":"Rasmussen","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.hoc.2007.08.005_bib23","series-title":"Hematology 2002: American Society of Hematology Education Program Book","first-page":"227","article-title":"Biology of myeloma bone disease","author":"Roodman","year":"2002"},{"issue":"13","key":"10.1016\/j.hoc.2007.08.005_bib24","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1182\/blood.V98.13.3534","article-title":"Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma","volume":"98","author":"Croucher","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Vacca","year":"1994","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.hoc.2007.08.005_bib26","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib27","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2003-11-3811","article-title":"Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression","volume":"104","author":"Kumar","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib28","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2002.05668.x","article-title":"Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance","volume":"97","author":"Malik","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1046\/j.1365-2141.2002.03912.x","article-title":"Helicobacter pylori infection and monoclonal gammopathy of undetermined significance","volume":"119","author":"Rajkumar","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0025-6196(12)60015-9","article-title":"\u201cBenign\u201d monoclonal gammopathy\u2014after 20 to 35 years of follow-up","volume":"68","author":"Kyle","year":"1993","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib31","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib32","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.hoc.2007.08.005_bib34","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1200\/JCO.2005.03.159","article-title":"Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance","volume":"23","author":"Kumar","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4065\/81.5.693","article-title":"Monoclonal gammopathy of undetermined significance, Waldenstr\u00f6m macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment","volume":"81","author":"Rajkumar","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.hoc.2007.08.005_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0025-6196(12)65225-2","article-title":"The spectrum of IgM monoclonal gammopathy in 430 cases","volume":"62","author":"Kyle","year":"1987","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib37","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1158\/1078-0432.CCR-04-1899","article-title":"Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?","volume":"11","author":"Gobbi","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.hoc.2007.08.005_bib38","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3816\/CLM.2005.n.013","article-title":"Prognostic factors for transformation in asymptomatic immunoglobulin M monoclonal gammopathies","volume":"5","author":"Morra","year":"2005","journal-title":"Clin Lymphoma"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3816\/CLM.2005.n.012","article-title":"Clinical characteristics and outcome of immunoglobulin M-related disorders","volume":"5","author":"Cesana","year":"2005","journal-title":"Clin Lymphoma"},{"issue":"21","key":"10.1016\/j.hoc.2007.08.005_bib41","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1200\/JCO.2005.06.147","article-title":"Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstr\u00f6m's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system","volume":"23","author":"Baldini","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9343(81)90326-0","article-title":"The clinical aspects of biclonal gammopathies. Review of 57 cases","volume":"71","author":"Kyle","year":"1981","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0248-8663(97)80618-2","article-title":"[Triclonal gammopathy and malignant immunoproliferative syndrome]","volume":"18","author":"Grosbois","year":"1997","journal-title":"Revue de Medecine Interne"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.10338","article-title":"Triclonal gammopathy in an extranodal non-Hodgkin lymphoma patient","volume":"73","author":"Tirelli","year":"2003","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.hoc.2007.08.005_bib45","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM198203113061002","article-title":"\u201cIdiopathic\u201d Bence Jones proteinuria: long-term follow-up in seven patients","volume":"306","author":"Kyle","year":"1982","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.1975.00330010064009","article-title":"Monoclonal gammopathy in lymphoma","volume":"135","author":"Alexanian","year":"1975","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.08.005_bib47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1309\/2A0FL1HM5PN2510P","article-title":"Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients","volume":"123","author":"Lin","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2007.08.005_bib48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.20157","article-title":"Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement","volume":"77","author":"Asatiani","year":"2004","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib49","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/87.3.385","article-title":"Monoclonal proteins in chronic lymphocytic leukemia","volume":"87","author":"Noel","year":"1987","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1297-319X(01)00343-8","article-title":"Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a literature review","volume":"69","author":"Lamboley","year":"2002","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.hoc.2007.08.005_bib51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/annonc\/mdh385","article-title":"The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance","volume":"15","author":"Sallah","year":"2004","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2007.08.005_bib52","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.hoc.2007.08.005_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F","article-title":"Autoantibodies associated with peripheral neuropathy","volume":"22","author":"Quarles","year":"1999","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.hoc.2007.08.005_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00415-005-0805-0","article-title":"Treatment of dys-immune neuropathies","volume":"252","author":"Nobile-Orazio","year":"2005","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.hoc.2007.08.005_bib56","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib57","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0190-9622(99)70434-2","article-title":"Monoclonal gammopathies and associated skin disorders","volume":"40","author":"Daoud","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib58","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/77.5.619","article-title":"Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance","volume":"77","author":"Mundis","year":"1982","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2007.08.005_bib59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/archinte.162.4.464","article-title":"Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: a prospective study","volume":"162","author":"Arnulf","year":"2002","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib60","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/lt.500020508","article-title":"Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder","volume":"2","author":"Badley","year":"1996","journal-title":"Liver Transpl Surg"},{"issue":"9","key":"10.1016\/j.hoc.2007.08.005_bib61","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","article-title":"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation","volume":"91","author":"Zent","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000168712","article-title":"Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients","volume":"14","author":"Rostaing","year":"1994","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9343(87)90659-0","article-title":"Recurrent febrile panniculitis and hepatitis in two patients with acquired complement deficiency and paraproteinemia","volume":"83","author":"Pascual","year":"1987","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.hoc.2007.08.005_bib64","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0002-9343(92)90749-2","article-title":"Control of systemic capillary leak syndrome with aminophylline and terbutaline","volume":"92","author":"Droder","year":"1992","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.hoc.2007.08.005_bib65","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2005.05.004","article-title":"Focal and segmental glomerulosclerosis and plasma cell proliferative disorders","volume":"46","author":"Dingli","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib66","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/archinte.161.6.864","article-title":"Monoclonal gammopathy of undetermined significance and exposure to breast implants","volume":"161","author":"Karlson","year":"2001","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.hoc.2007.08.005_bib67","first-page":"350","article-title":"Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias","volume":"13","author":"Merlini","year":"1986","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2007.08.005_bib68","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","article-title":"Solitary plasmacytoma of bone and asymptomatic multiple myeloma","volume":"96","author":"Dimopoulos","year":"2000","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2007.08.005_bib69","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880700113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:51:56Z","timestamp":1760183516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880700113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S088985880700113X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2007.08.005","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2007.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}